Breast Cancer Risk Study University of Melbourne
Filed with ASX · · 2 pages · English
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- Quarterly Activities Report and Appendix 4C 31 March 2025
- EGM - Investor Presentation
- RHY Genetype Commercial Sales
- RHY Investor Webinar
- Genetype Commercial Integration Completion
Later from Rhythm Biosciences
- ColoSTAT Beta kit verification and validation update
- NATA Accreditation Awarded for Genetype Laboratory
- FY2025 R&D Tax Incentive Loan Funding
- Jun 25 Quarterly Activities Report and Appendix 4C
- ColoSTAT Kits Deliver Breakthrough Results
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences